CSF1 and central nervous system cancer: Higher expression level was associated with higher survival rate in patients with primary and recurrent glioma, as well as in vitro, upregulated miR-1254 decreased glioma cells invasive, migratory and proliferative potentials via direct targeting of CSF-1, which is known to regulate macrophage motility, migration and maturation (164, 165).